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Abstract
Objective. There is a need for reliable and valid clinical assessment tools for quantifying allodynia in neuropathic
pain. Allodynography has been proposed as a useful standardized procedure for clinical assessment of mechanical
allodynia. This study (www.clinicaltrials.gov NCT02070367) undertook preliminary investigation of the measurement
properties of allodynography, a new standardized clinical examination procedure for mapping the area of cutaneous
allodynia. Methods. Persons with pain in one upper extremity after complex regional pain syndrome, a peripheral
nerve injury, or who had recently experienced a hand fracture were recruited for assessment of static mechanical
allodynia (based on perception of a 15g force stimulus delivered by Semmes-Weinstein monofilament #5.18 as pain-
ful) by two raters at baseline; the assessment was repeated one week later. Results. Single-measures estimates sug-
gested inter-rater reliability for allodynography was excellent at an intraclass correlation coefficient (ICC) of 0.97
(N¼ 12); test–retest reliability was also excellent at ICC¼0.89 (N¼ 10) for allodynography (P< 0.001 for both).
Confidence intervals’ lower bounds confirm inter-rater reliability as excellent (0.90) but were less definitive for test–
retest (0.59). Conclusions. This preliminary study supports the inter-rater and test–retest reliability of allodynography.
Studies on larger samples in multiple contexts and reporting other measurement properties are warranted.
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Introduction
Allodynia is commonly referred to as hypersensitivity but
is more precisely defined as “pain due to a stimulus
which does not normally provoke pain” [1]. It is
frequently associated with neuropathic pain and/or the
resultant peripheral and central sensitization [2–4].
Allodynia adds to the clinical challenge of effective man-
agement for a spectrum of conditions, including burns,
peripheral nerve and plexus injuries, post-herpetic
neuralgia, and complex regional pain syndrome (CRPS)
[5–8]. For research purposes, mechanical allodynia (MA)
is often measured dynamically by stroking the tender
area of the skin with a brush; however, both the tools
and techniques used are difficult to standardize in the
clinical setting because of variability in application force,
distance, and speed [9]. Furthermore, it is generally used
for diagnostic purposes, and the responsiveness to change
remains to be established [10]. A need exists for clinically
useful but accurate evaluations for the identification and
quantification of allodynia and monitoring of changing
allodynia over time.
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which should be cited to refer to this work.
The Somatosensory Rehabilitation Method (SRM) has
been proposed as a nonpharmacological treatment for
neuropathic pain, including allodynia [11]. It uses the
principles of somatosensory re-education through tar-
geted comfortable sensory stimulation (e.g., mindful per-
ception of the different textures and temperatures of
materials, and the dynamics and intensity of the applica-
tion of the stimulus) based on contemporary understand-
ings of the function and dysfunction of the
somatosensory system [12]. To tailor the intervention, it
relies on first precisely defining the topographical terri-
tory demonstrating static mechanical allodynia (SMA)
using a standardized procedure of testing with a cali-
brated monofilament, known as allodynography [12,
13]. This strategic consideration of the peripheral nerve
branches residing in the painful territory is used to form
a neuroanatomic hypothesis [14] to inform the
application of comfortable tactile or vibratory
“counterstimulation” to a distant zone of a neuroana-
tomically related cutaneous nerve branch [12].
For an objective clinical examination procedure to
have utility as a diagnostic indicator, it requires three
psychometric properties: validity, reliability, and respon-
siveness to change [15]. The validity of allodynography
to diagnose Ab axonal lesions has already received some
preliminary examination [13, 16]. From these findings, it
can be postulated that patients report symptoms of neu-
ropathic pain because of lesions of the Ab fibers of a cu-
taneous nerve branch [17, 18]. However, the reliability
and responsiveness to change of allodynography have not
been formally evaluated in the literature.
Purpose of the Study
The purpose of this study was to evaluate persons with
allodynia to estimate the reliability of a new clinical ex-
amination to map the allodynic territory. Therefore, our
primary research question was as follows: Is allodynogra-
phy a reliable assessment tool for describing the allodynic
territory? The secondary question as follows: What is the
inter-rater agreement for the formation of a clinical neu-
roanatomic hypothesis?
Methods
Design and Setting
This study was conducted at the outpatient hand rehabil-
itation clinic at a regional trauma center and teaching
hospital in Hamilton, Ontario, as part of a prospective
pilot study examining the somatosensory rehabilitation
method (the SARA study: www.clinicaltrials.gov
NCT02070367). Data were collected between September
2014 and January 2017. Baseline evaluations were con-
ducted by the first author (an occupational therapist and
Certified Somatosensory Therapist for Pain [CSTP]) [19]
and one of two other independent evaluators (one phys-
iotherapist, one occupational therapist) who had basic
training (about six hours) in the allodynography proce-
dure. All participants gave written informed consent, and
the study was approved by the local ethics committee
(Hamilton Integrated Research Ethics Board).
Subjects
Participants were recruited from local hand therapy facil-
ities and pain programs. Inclusion criteria were 1) a diag-
nosis of CRPS meeting the Budapest criteria [20] in a
single upper limb, 2) a unilateral peripheral nerve injury
(PNI) in the upper limb verified intra-operatively, or 3) a
recent hand fracture (clinically stable but still requiring
rehabilitation). Inclusion criteria were confirmed by med-
ical record to ensure eligibility. Exclusion criteria were
the presence of open wounds, other forms of nerve com-
pression or dysfunction (i.e., radiculopathy, diabetic pe-
ripheral neuropathy) or inability to complete the study
questionnaires in English. The screening process for allo-
dynia is described below. The target sample size for the
explorations of reliability was set at N¼ 35 using
Donner’s estimates to achieve substantial reliability at
80% power over two test occasions [21].
Evaluations
All participants were screened for SMA using standard-
ized procedures: 1) they were asked to point (without
touching) to indicate their most painful area, 2) partici-
pants rated (using a four-point always/often/sometimes/
never scale) if the pain became worse with movement or
touch and/or if it occurred spontaneously, and 3) a single
stimulus of two seconds’ duration with a 15g monofila-
ment applied (after demonstration on their nonpainful
limb), and the person was asked if it produced pain (yes
or no). If they answered yes, then the examiner proceeded
with the allodynography procedure.
Allodynography
Allodynography is a standardized clinical examination
procedure for mapping the borders of the cutaneous terri-
tory where application of a 15g force stimulus (Semmes-
Weinstein monofilament #5.18) on the skin generates a
painful response (defined as 30mm on a 100-mm visual
analog scale [VAS] or pain at rest þ 10mm on a 100-mm
VAS) [13]. With the client in a comfortable position,
with the limb supported and the painful area of skin ex-
posed, the stimulus was applied for two seconds, starting
proximally to the pain. Subsequent stimuli were applied
in 1-cm increments proceeding distally down the central
axis of the limb, with an interstimulus interval of
10 seconds. The client was asked to say “STOP” when
they experienced pain (as defined above ¼ 30mm on a
VAS). After “STOP” was indicated, the tester moved
back 1 cm, and then advanced in 1-mm increments until
“STOP” was indicated again: this point was recorded
with a dot of water-soluble ink. This procedure was re-
peated, starting distally on the same limb axis, and
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moving proximally, until again the client indicated
“STOP” (see Figure 1 for an illustrative photograph). A
transverse axis roughly bisecting the painful area was
similarly evaluated. The territory of the allodynography
was measured using anatomical landmarks (recording
the distance from the landmark to the final “STOP” point
on each axis) and recorded visually on graph paper (see
Spicher et al. [12] for a detailed description of the proce-
dure). For precision in our study, we asked the participant
to identify when the qualities of the stimulus perception
started to change. At that point, we would tap the mono-
filament on a water-based ink pad before subsequent ap-
plication of every stimulus and switch to 1-mm
increments, thus creating an accurate measurement point
to record the “STOP” point when the subject indicated a
painful response, without the need to reverse. Four
“STOP” points were identified and measured with a flexi-
ble clear plastic ruler held approximately 2 cm above the
skin. These were recorded visually on a standardized dia-
gram (front and back of right and left hands) with the
measurement indicators (Figure 2). To pragmatically ac-
count for the nonrectangular shape of the allodynic terri-
tory, we calculated the area of allodynia as length (most
proximal and distal points identified) * width (most lateral
points identified) * 0.66 (Figure 2).
The second step of allodynography is the formation of
a clinical neuroanatomic hypothesis proposing which cu-
taneous nerve branch might be implicated as the site of the
painful nerve lesion [14, 18, 22]. This hypothesis is derived
from the known innervation territory situated within the
allodynia map that has been generated from the monofila-
ment testing: Within the SRM, it is critical for subsequent
development of the treatment plan. For the purposes of
our study, a single allodynography map was developed for
the territory identified by the participant as the most pain-
ful area. Raters were provided with the most recent ver-
sion of a clinical atlas of the cutaneous nerve origins [22]
to use as a reference when generating these hypotheses.
McGill Pain Questionnaire
The other established outcome measure used in the
SRM is the McGill Pain Questionnaire (MPQ) [23]. The
original English version of the MPQ is comprised of 78
pain descriptors: words are further arranged in 20 con-
struct clusters (e.g., temporal, spatial, thermal) [24].
The person is instructed to first choose all words de-
scribing their current pain (yielding a total number of
words/78). From these chosen words, the “best” word
from each cluster is rated using a 0–5 scale with quali-
fiers (0¼ absent, 1¼mild, 2¼ discomforting,
3¼ distressing, 4¼ horrible, 5¼ excruciating) to indi-
cate the intensity of the pain quality at the present time.
We then summed these ratings and converted to percent
scores for ease of interpretation, yielding a total score of
tMPQ/100, a sensory pain score of (sMPQ)/65, and an
affective pain score of (aMPQ)/35, following the SRM
recommendations [12].
Statistical Analysis
After data screening, demographics and clinical variables
were described with means 6 SDs for continuous
Figure 1. Allodynography testing. Note the limb is stabilized on
a cushion, while the filament is carefully applied with sufficient
pressure until slight bowing is observed. This photograph
illustrates the second step of evaluation, working from proxi-
mal to distal down the central limb axis on the volar surface to-
wards the area of allodynia (in distal forearm for this
participant).
Figure 2. Sample allodynia map. a) Neuroanatomic hypothesis
designates the cutaneous nerve branch related to the mapped
territory. b) Arrows indicate the direction of testing, while the
dot indicates where the subject indicated ’STOP’. c) Triangle
indicates invariant measurement reference point (an anatomi-
cal landmark). d) Star indicates the point where the rainbow
pain scale rating was tested [12].
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variables and frequencies and percentages for categorical
variables. A contingency table was generated to examine
the proportion of persons from each diagnostic group
who were identified as having allodynia, and the Fisher
exact test was used to calculate the significance. To cal-
culate inter-rater and test–retest reliability for allody-
nography, intraclass correlation coefficients (ICCs) for
individual measures were used. Agreement for clinical
neuroanatomic hypothesis formation was estimated us-
ing Spearman’s rho (r) statistic; each nerve branch in the
upper extremity was given a numerical “dummy” code.
All analyses were performed with STATA 13, with sta-
tistical significance set at P¼ 0.05 unless otherwise
noted.
Results
Although 38 persons were recruited to this study, not all
data sets are complete, as a result of some participants
declining to complete portions of the evaluations; we
have therefore reported the sample size separately for
each analysis. Table 1 contains a description of
participant demographic and clinical characteristics. The
frequency at which SMA was identified across diagnostic
groups is documented in Table 2; the Fisher exact test
was significant at 0.045.
For examining the inter-rater reliability of allodynog-
raphy, we had 12 cases with repeated measures at base-
line representing those participants who 1) had allodynia
according to our definition of pain with a static touch of
15g and therefore were eligible for mapping and 2)
consented to the procedure with both raters. In those per-
sons, we found an excellent intraclass correlation
Table 1. Participant demographics and baseline characteristics (N¼38)
Characteristic Mean SD Range
Age 45.9 14.4 15–76
Duration of injury or pain, mo 17.9 38.5 1–168
Shoulder flexion (% of unaffected side) 88.8 20.3 0–100
Wrist extension, % of unaffected side 74.5 23.6 0–100
Forearm supination, % of unaffected side 84.8 13.3 38.9–100
Grip strength, kg R ¼ 24.4 19.2 0–63.3
L ¼ 26.6 16.6 0–54.7
% of normal grip in affected hand 39.1 29.7 0–90.1
Total No. of words from MPQ 24.7 16.3 0–64
Total MPQ score (tMPQ/100) 38.3 26.4 0–93
Allodynography (N ¼ 16 persons, rater 1), area in cm2 136.5 117.2 12.3–349.4
Characteristic Frequency Percentage
Gender M ¼ 19 M ¼ 50
F ¼ 19 F ¼ 50
Diagnosis CRPS ¼ 20 52.6
PNI ¼ 10 26.3
Fracture ¼ 8 21.1
Dominance R ¼ 32 R ¼ 84
L ¼ 6 L ¼ 15.8
Side of injury R ¼ 24 R ¼ 63.2
L ¼ 14 L ¼ 36.8
Patient-reported pain with movement or touch (N ¼ 35) None ¼ 4 None ¼ 11.4
Sometimes ¼ 7 Sometimes ¼ 20
Often ¼ 7 Often ¼ 20
Always ¼ 17 Always ¼ 48.6
Patient-reported spontaneous pain (N ¼ 35) None ¼ 7 None ¼ 20
Sometimes ¼ 10 Sometimes ¼ 28.6
Often ¼ 9 Often ¼ 25.7
Always ¼ 8 Always ¼ 22.9
Allodynia present Yes ¼ 17 Yes ¼ 44.7
(reports pain with 15g filament applied) No ¼ 18 No ¼ 47.4
Declined ¼ 3 Declined ¼ 7.9
CRPS ¼ complex regional pain syndrome; PNI ¼ peripheral nerve injury; tMPQ ¼McGill Pain Questionnaire total score.
Table 2. Frequency of positive screening results for static
mechanical allodynia by diagnostic group (N¼35)
Diagnostic Group No Allodynia Allodynia Total
CRPS 6 12 18
PNI 5 4 9
Fracture 7 1 8
Totals 18 17 35
CRPS ¼ complex regional pain syndrome; PNI ¼ peripheral nerve injury.
Fisher exact P ¼ 0.045.
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coefficient (ICC) of 0.97 (95% confidence interval
[CI]¼ 0.90–0.99) for single measures and 0.99 (95% CI
¼ 0.95–0.99) for average measures (P< 0.001 for both).
Test–retest reliability of allodynography, based on rat-
ings of the same persons (N¼ 10) by a single rater one
week apart, was estimated at ICC2,1 ¼ 0.89 (95%
CI¼ 0.59–0.97, P< 0.001) for single measures and
ICC2,1 ¼ 0.94 (95% CI¼ 0.74–0.99) for average meas-
ures (P< 0.001).
The final rating of agreement we explored in this
study was the clinical neuroanatomic hypothesis formed
by each rater independently after completing the allody-
nography. Inter-rater agreement across the 12 cases was
excellent [25], at Spearman’s r¼ 0.91 (P< 0.001).
Discussion
Reliability
This clinical measurement study of allodynography has
generated preliminary support for the reliability of this
objective clinical examination procedure. Our single-
measures estimate suggested that the reliability for allo-
dynography was excellent at ICC¼ 0.97 (95% CI ¼
0.90–0.99). However, Donner’s estimates for the mini-
mum number of subjects required to achieve 0.80 power
for inter-rater reliability based on single ratings by two
raters [21] suggest 12 subjects as adequate to demon-
strate only slight reliability. Despite the potential under-
powering, this estimate was statistically significant with
a relatively small confidence interval. Our test–retest reli-
ability estimates for allodynography were from only 10
subjects. The decrease in sample size at follow-up is
reflected in both the lower ICC estimate (ICC¼ 0.89)
and larger confidence interval (95% CI ¼ 0.59–0.97)
when compared with the inter-rater reliability estimates.
The difference illustrates greater variability between test
occasions than between two raters on the same occasion.
This suggests that there may be some instability of the
map from day to day, posing a potential threat to respon-
siveness. In clinical application, this symptom variability
underpins Spicher’s recommendations for 1) frequency of
re-evaluation (monthly) [12] and 2) repeated testing one
week later after a negative allodynography (that is, no
territory of painful skin is identified related to stimula-
tion with a 15g monofilament) before progressing so-
matosensory treatment from distant counterstimulation
to decrease allodynia to somatosensory re-education for
underlying hypoesthesia [19]. It is also important to note
SMA was identified in all diagnostic groups, albeit at dif-
ferent rates (Fisher exact test P¼ 0.045). Further, the
high level of agreement between raters for the resultant
neuroanatomic hypothesis positing which specific cuta-
neous nerve branch was involved reinforces the reliability
of the examination procedure. From a clinical stand-
point, our identification of a person with mechanical
allodynia postfracture may also have relevance; the
detailed diagnostic code for this individual revealed that
they had had a fracture with percutaneous pinning. The
allodynia seen may represent nerve irritation related to
fracture management.
Allodynography uses a standardized stimulus (15g
#5.18 monofilament) and defines pain (the targeted per-
ception) as 30mm on a VAS or pain at rest þ 10mm on
a VAS. This standard was derived from earlier attempts
to categorize VAS scores, where 85% of persons report-
ing moderate pain also gave a VAS rating of at least
30mm [26]. Although more recent work suggests a cut-
point of 34mm for mild pain [27], our experience is that
the 30-mm standard is clinically useful and easily under-
stood by the persons being tested. On the basis of a stan-
dardized stimulus combined with a rated perceptual
response, allodynography should be considered a form of
psychophysical clinical examination [28].
Utility Considerations
A positive allodynography, combined with the formation
of clinical neuroanatomic hypothesis, meets the diagnos-
tic standards for a probable diagnosis of neuropathic
pain [14]. In the SRM, the ability to identify underlying
somatosensory tactile hypoesthesia (termed a positive
secondary aesthesiography) [13, 19] after reduction and
total resolution of the mapped allodynia provides a form
of criterion validation: the pathognomonic hypoesthesia
of a nerve lesion is only unmasked by resolution of the
allodynia [13, 16, 29]. The reliability of this standardized
clinical examination procedure adds to previous valida-
tion work [13, 16] and creates a foundation for further
explorations of validity, such as comparison with other
forms of screening for neuropathic pain [30].
Allodynography provides a clinical sign for static me-
chanical allodynia that cannot be quantified by standard
electrophysiological testing [28, 31]. As the monofilament
tests receptor field after receptor field as it moves down the
limb axis, allodynography is objectively signaling the pres-
ence of Ab axonal lesions—not C-fiber lesions, as would be
induced by hyperalgesia to pin prick [32]. Allodynography
makes use of inexpensive somatosensory evaluation equi-
pment and is aligned with calls to increase the use of stan-
dardized evaluations for both neuropathic and chronic
musculoskeletal pain [30, 33, 34]. Further, the results are
useful to inform treatment planning by giving precise guid-
ance regarding which areas should not be flooded with sen-
sory stimuli to limit evocation of abnormal pain signaling,
and where instead to focus on sensory retraining to address
sensory loss on adjacent areas. In rehabilitation, such non-
pharmacological interventions may include providing ad-
vice on activity modification, use of orthoses or adaptive
equipment, and tailoring of exercise programs to minimize
repetitive motions evoking pain [11, 19].
Allodynography, the clinical examination procedure
described here for mapping a territory of painful somato-
sensory abnormality [34], differs from other descriptions
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in the literature. LaMotte et al. [29] described use of a
von Frey–type nylon monofilament of 225mN (22.9g) of
force, applied in 5-mm increments along at least eight lin-
ear pathways radiating from the painful site, with a dura-
tion of 0.5 to one second, and a delay between stimuli of
approximately three seconds. Stop points were marked
on the skin with felt pen and then traced onto an acetate
sheet for subsequent computerized analysis of the area
[29]. Wallace et al. refined LaMotte’s eight-pathway
technique using a 12.9g monofilament advanced in 1-cm
increments [35]. They recorded this static form of
mechanical sensory testing in combination with brush-
stroking to map dynamic allodynia and reported the
results as an end point showing statistically significant
change in several randomized controlled trials of neuro-
pathic pain agents [35, 36]. They also used acetates and
technology to generate the area calculations, but noted at
times that the allodynic territory was larger than a single
sheet of acetate, necessitating other forms of recording
[35]. Walk et al. included mapping in their recommended
clinical protocol for the evaluation of neuropathic pain
[34] but did not provide “how to” guidance beyond
referencing earlier papers [29, 35, 36]. Other authors
evaluating neuropathic and musculoskeletal pain have
used a matrix method of evaluating a grid of predeter-
mined anatomical points and recorded the pressure pain
threshold at each site [37, 38].
Standardization
Our procedure for allodynography, where application of
a 15g force on the skin generates a painful response (de-
fined as 30mm on a VAS or pain at rest þ 10mm on a
VAS), uses a commonly available Semmes-Weinstein sen-
sory evaluation kit stimulus (#5.18). In this study, we
added precision to the notation by using the monofila-
ment itself and a water-based ink pad to mark the bor-
ders of the territory. Spicher advocates measurement of
four points on standard a x/y-axis relative to a fixed ana-
tomic reference point [18]: for the purposes of calculating
reliability in this study, we used these measurements as
the basis for our calculations of area but applied a stan-
dard adjustment (0.66) to account for the nonlinear
shape. In clinical practice, we have found that the linear
measurements without the calculation of area are suffi-
cient to monitor change and are easy to execute using an
inexpensive flexible clear plastic ruler. Additionally,
when measuring over the contours of the hand, we have
also found it useful to include additional measurement
points for monitoring of change.
The allodynography procedure is in contrast to the re-
peated stimuli applied using the method of limits by
Keizer et al. [39], who used von Frey monofilaments to
establish a minimum threshold of allodynia in persons
with allodynia in a single limb. They asked the subjects
to indicate the most painful area of the skin, and this was
compared bilaterally by testing with progressively larger
monofilaments. Once the person perceived two of three
stimuli to be painful (most commonly at #4.56 pressure),
they were also asked to rate the intensity of the pain
evoked: reporting a mean evoked pain of 6.8/10 on a nu-
meric rating scale (range ¼ 4–9). However, they reported
that none of their subjects found any size of monofila-
ment to be painful on the nonaffected limb, including an
additional five healthy volunteers tested [39]. This is con-
cordant with our findings of only 12 persons of the 38
tested meeting our criterion for allodynia (i.e., perceiving
pressure from a #5.18 monofilament as evoking pain of
at least 3/10 on a VAS). It is also worth noting the make-
up of our sample: while we also tested persons with re-
cent fractures and peripheral nerve injuries, 50% of the
sample met the Budapest criteria for CRPS. The unique
features of this syndrome may reflect a severity bias in
our sampling, and the measurement properties reported
here may not generalize to more heterogeneous samples.
Limitations and Recommendations for Future
Research
It is important to note some participants declined re-
peated testing, or declined evaluation with monofila-
ments altogether. We cannot know if this group would
represent important data that would influence the values
and relationships reported here, although our general ob-
servation is that this may reflect persons with chronic
symptoms and high levels of catastrophizing. All of our
participants had a history of upper limb injury, and the
measurement estimates were on the basis of evaluations
of the hand and upper limb. More research on the mea-
surement properties of these evaluations should be con-
ducted in larger samples including other cutaneous areas
in the body and other forms of neuropathic pain.
Conclusions
This initial investigation of the measurement properties
of allodynography supports at least fair inter-rater and
test–retest reliability of the method in persons with
CRPS, peripheral nerve injuries, or pain after hand frac-
ture when conducted by trained therapists and good
agreement for the formation of a neuroanatomic hy-
pothesis. However, more study in larger and diverse
samples is needed to generate estimates of criterion and
construct validity and responsiveness to change if the
method is to be used in research and clinical practice. The
results presented here can inform the rigor and scope of
those investigations. We leave the reader with a quote from
a paper published by the Neuropathic Pain Research
Consortium [34]:
Novel clinical observations emerge from novel methods
of observation and measurement. Therefore, the advance-
ment of our understanding of neuropathic pain is depen-
dent upon the development of tools to observe the phe-
nomenon of neuropathic pain. As neuropathic pain is a
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fundamentally clinical physiologic phenomenon rather
than a histologic, electrophysiologic, or laboratory phe-
nomenon, the fundamental tools for the study of neuro-
pathic pain must be clinical. (p. 639)
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